CRC
BLFS icon

Curi RMB Capital’s BioLife Solutions BLFS Stock Holding History

Curi RMB Capital’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-426,015
Closed -$8.13M – 912
2026
Q1 		$8.13M Buy
426,015
+2,473
+0.6% +$54.7K 0.14% 162
2025
Q4 		$10.2M Sell
423,542
-8,582
-2% -$225K 0.18% 136
2025
Q3 		$11M Sell
432,124
-16,234
-4% -$385K 0.2% 128
2025
Q2 		$9.66M Buy
448,358
+9,673
+2% +$218K 0.18% 145
2025
Q1 		$10M Buy
438,685
+4,870
+1% +$128K 0.25% 118
2024
Q4 		$11.3M Buy
433,815
+11,882
+3% +$296K 0.26% 122
2024
Q3 		$10.6M Buy
421,933
+2,283
+0.5% +$53.9K 0.24% 127
2024
Q2 		$8.99M Sell
419,650
-1,576
-0.4% -$30.6K 0.22% 137
2024
Q1 		$7.81M Buy
421,226
+22,455
+6% +$393K 0.18% 152
2023
Q4 		$6.48M Sell
398,771
-713
-0.2% -$9.1K 0.2% 131
2023
Q3 		$5.52M Buy
399,484
+45,394
+13% +$715K 0.19% 131
2023
Q2 		$7.83M Buy
354,090
+7,628
+2% +$161K 0.26% 108
2023
Q1 		$7.54M Buy
346,462
+15,485
+5% +$348K 0.26% 108
2022
Q4 		$6.02M Sell
330,977
-12,966
-4% -$268K 0.21% 124
2022
Q3 		$7.83M Sell
343,943
-7,023
-2% -$150K 0.29% 100
2022
Q2 		$4.85M Buy
350,966
+25,986
+8% +$381K 0.17% 134
2022
Q1 		$7.39M Buy
324,980
+38,643
+13% +$1.02M 0.23% 111
2021
Q4 		$10.7M Buy
286,337
+8,005
+3% +$344K 0.32% 86
2021
Q3 		$11.8M Sell
278,332
-5,247
-2% -$253K 0.39% 79
2021
Q2 		$12.6M Buy
283,579
+89,677
+46% +$3.16M 0.42% 72
2021
Q1 		$6.98M Buy
+193,902
New +$7.67M 0.26% 105

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Curi RMB Capital's BLFS Position: Q2 2026 in Review

Curi RMB Capital sold out of BioLife Solutions (BLFS) in Q2 2026, closing a stake of 426,015 shares — an estimated $8.13M sold.

Curi RMB Capital first reported a position in BLFS in Q1 2021 and held it in 21 quarters. The position peaked at $12.6M in Q2 2021. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Curi RMB Capital reported no remaining BioLife Solutions position as of Q2 2026 after selling out during the quarter.
  • Curi RMB Capital sold 426,015 BioLife Solutions shares in Q2 2026, an estimated $8.13M.
  • Curi RMB Capital first reported a position in BioLife Solutions in Q1 2021 and held it in 21 quarters.
  • Curi RMB Capital's BioLife Solutions position peaked at $12.6M in Q2 2021.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.